Clinical evaluation of self-collected saliva by quantitative reverse transcription-PCR (RT-qPCR), direct RT-qPCR, reverse transcription–loop-mediated isothermal …
M Nagura-Ikeda, K Imai, S Tabata… - Journal of clinical …, 2020 - Am Soc Microbiol
The clinical performances of six molecular diagnostic tests and a rapid antigen test for severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were clinically evaluated for the …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were clinically evaluated for the …
Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis
S Tabata, K Imai, S Kawano, M Ikeda… - The Lancet Infectious …, 2020 - thelancet.com
Background The ongoing COVID-19 pandemic is a global threat. Identification of markers
for symptom onset and disease progression is a pressing issue. We described the clinical …
for symptom onset and disease progression is a pressing issue. We described the clinical …
Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19
K Imai, S Tabata, M Ikeda, S Noguchi, Y Kitagawa… - Journal of clinical …, 2020 - Elsevier
Background We evaluated the clinical performance of an immunochromatographic (IC) IgM/IgG
antibody assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and …
antibody assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and …
Clinical evaluation of self-collected saliva by RT-qPCR, direct RT-qPCR, RT-LAMP, and a rapid antigen test to diagnose COVID-19
M Ikeda, K Imai, S Tabata, K Miyoshi, N Murahara… - MedRxiv, 2020 - medrxiv.org
Background The clinical performance of six molecular diagnostic tests and a rapid antigen
test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were clinically …
test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were clinically …
Antibody response patterns in COVID‐19 patients with different levels of disease severity in Japan
K Imai, Y Kitagawa, S Tabata, K Kubota… - Journal of medical …, 2021 - Wiley Online Library
We analyzed antibody response patterns according to the level of disease severity in
patients with novel coronavirus disease 2019 (COVID‐19) in Japan. We analyzed 611 serum …
patients with novel coronavirus disease 2019 (COVID‐19) in Japan. We analyzed 611 serum …
The clinical characteristics of COVID-19: a retrospective analysis of 104 patients from the outbreak on board the Diamond Princess cruise ship in Japan
S Tabata, K Imai, S Kawano, M Ikeda, T Kodama… - MedRxiv, 2020 - medrxiv.org
Background The ongoing outbreak of the coronavirus disease 2019 (COVID-19) is a global
threat. Identification of markers for symptom onset and disease progression is a pressing …
threat. Identification of markers for symptom onset and disease progression is a pressing …
[HTML][HTML] Non-severe vs severe symptomatic COVID-19: 104 cases from the outbreak on the cruise ship “Diamond Princess” in Japan
S Tabata, K Imai, S Kawano, M Ikeda, T Kodama… - MedRxiv, 2020 - medrxiv.org
Background The ongoing outbreak of 2019 novel coronavirus disease (COVID-19) is a
global threat. Clarifying its clinical features such as risk factors for disease progression is a …
global threat. Clarifying its clinical features such as risk factors for disease progression is a …
[HTML][HTML] Cross-reactive humoral immune responses against seasonal human coronaviruses in COVID-19 patients with different disease severities
K Imai, M Matsuoka, S Tabata, Y Kitagawa… - International Journal of …, 2021 - Elsevier
Background: The cross-reactive antibody response against seasonal human coronaviruses (HCoVs)
was evaluated according to disease severity in patients with COVID-19 in Japan. …
was evaluated according to disease severity in patients with COVID-19 in Japan. …
Idiopathic multicentric castleman disease with autoimmune hemolytic anemia and production of anti-drug antibody against tocilizumab
S Tabata, T Higuchi, S Tatsukawa, K Narimatsu… - Internal …, 2019 - jstage.jst.go.jp
Idiopathic multicentric Castleman disease (iMCD) is a rare lymphoproliferative disorder, and
only a few cases have been reported to be complicated with autoimmune hemolytic anemia …
only a few cases have been reported to be complicated with autoimmune hemolytic anemia …
Clinical characteristics and antibody response to SARS-CoV-2 spike 1 protein using VITROS Anti-SARS-CoV-2 antibody tests in COVID-19 patients in Japan
…, Y Kitagawa, M Matsuoka, S Tabata… - Journal of Medical …, 2021 - microbiologyresearch.org
Introduction. Serological tests for COVID-19 are important in providing results for surveillance
and supporting diagnosis. Investigating the serological response in COVID-19 patients …
and supporting diagnosis. Investigating the serological response in COVID-19 patients …